Search

Author/Creator Rivera, F

3. Genotype-based selection of treatment of patients with advanced colorectal cancer (SETICC): a pharmacogenetic-based randomized phase II trial. (14th November 2017)

Authors:
Abad, A; Martínez-Balibrea, E; Viéitez, J M; Alonso-Orduña, V; García Alfonso, P; Manzano, J L; Massutí, B; Benavides, M; Carrato, A; Zanui, M; Gallego, J; Grávalos, C; Conde, V; Provencio, M; Valladares-Ayerbes, M; Salazar, R; Sastre, J; Montagut, C; Rivera, F; Aranda, E
Journal:
Annals of oncology
Issue:
Volume 29:Number 2(2018)
Page Start:
439
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. O-015A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results. (20th June 2018)

Authors:
Chiritescu, G; Dumon, K; Mercadé, T Macarulla; Lang, I; Vivas, C Santos; Papai, Z; Janssens, J; Hendrickx, K; Pracht, M; Van den Eynde, M; Taïeb, J; Moons, V; Geboes, K; Van Laethem, J; Greil, R; Cervantes, A; Vergauwe, P; Ferrante, M; Vanderstraeten, E; Fridrik, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. O-026Results of REARRANGE trial: A randomized phase 2 study comparing different dosing approaches for regorafenib (REG) during the first cycle of treatment in patients (pts) with metastatic colorectal cancer (mCRC). (2nd July 2019)

Authors:
Argiles, G; Margalef, N Mulet; Valladares-Ayerbes, M; de Prado, J Vieitez; Grávalos, C; Alfonso, P García; Santos, C; Tobeña, M; Sastre, J; Benavides, M; Cano, T; Loupakis, F; Garrote, M Rodriguez; Rivera, F; Goldberg, R; Falcone, A; Bennouna, J; Ciardiello, F; Tabernero, J; Aranda, E
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 4
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. PD-012Early tumour shrinkage (ETS) and its impact on tumour-related symptoms in patients with previously untreated RAS wild-type metastatic colorectal cancer (mCRC): A retrospective analysis of three panitumumab studies. (20th June 2018)

Authors:
Taieb, J; Geissler, M; Rivera, F; Karthaus, M; Wilson, R; Loupakis, F; Price, T; Tracy, M; Burdon, P; Peeters, M
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 5
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. P–708 Comparison of reproductive outcomes after progestin-primed ovarian stimulation with dydrogesterone versus cetrorelix to inhibit spontaneous ovulation in oocyte donation. (6th August 2021)

Authors:
Moreno, J A; Masoli, P; Sferrazza, C; Leiva, H; Espinosa, O; Hernande. . Rudnick, P; Lizardo, J; Rivera, F; Plaz. d. lo. Reyes, S; Cordova, M; Sferrazza, E; Chavez, N; Sepulveda, M; Jiliberto, B
Journal:
Human reproduction
Issue:
Volume 36:Supplement 1(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗